Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 3,066 $ 4,455
Accounts receivable, net 5,371 4,354
Notes receivable 2,211
Inventories 3,869 6,611
Prepaid expenses and other current assets 484 812
Total Current Assets 15,001 16,232
Fixed assets, net 138 230
Right-of-use assets, operating leases 64 120
Goodwill 405
Other assets 193 155
Total Assets 15,801 16,737
Current Liabilities    
Accounts payable 3,137 6,928
Accrued and other liabilities 1,535 2,085
Line of credit 2,414 1,741
Term loan, net 2,881
Operating lease liability 62 57
Total Current Liabilities 7,148 13,692
Non-current Liabilities    
Operating lease liability 5 67
Total Non-current Liabilities 5 67
Total Liabilities 7,153 13,759
Stockholders’ Equity    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 1,830,097 & 729,026 shares issued and outstanding as of December 31, 2024 and 2023, respectively 2 32
Additional paid-in capital 330,156 324,288
Accumulated deficit (321,510) (321,342)
Total Stockholders’ Equity 8,648 2,978
Total Liabilities and Stockholders’ Equity $ 15,801 $ 16,737